NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-256-1999-0-DE-07 Determination of Adrenomedullin-Binding Proteins DE EP 00961705.1 Abandoned
NCI E-256-1999-0-FR-09 Determination of Adrenomedullin-Binding Proteins FR EP 00961705.1 Abandoned
NCI E-256-1999-0-PT-12 Determination of Adrenomedullin-Binding Proteins PT EP 00961705.1 Abandoned
NCI E-256-1999-0-ES-11 Determination of Adrenomedullin-Binding Proteins ES EP 00961705.1 Abandoned
NCI E-256-1999-0-IT-10 Determination of Adrenomedullin-Binding Proteins IT EP 00961705.1 Abandoned
NCI E-256-1999-0-EP-05 Determination of Adrenomedullin-Binding Proteins EP National Stage 00961705.1 Abandoned
NCI E-256-1999-0-AU-03 Determination of Adrenomedullin-Binding Proteins AU National Stage 73622/00 Abandoned
NIDCR E-160-2000-0-AU-05 T2R, a Novel Family of Taste Receptors AU National Stage 73664/00 Abandoned
NCI E-256-1999-0-PCT-02 Determination of AM-Binding Proteins and the Association of Adrenomedullin (AM) Therewith PCT PCT PCT/US00/24722 Expired
NIDCR E-160-2000-0-PCT-02 T2R, A NOVEL FAMILY OF TASTE RECEPTORS PCT PCT PCT/US2000/024821 Abandoned
NCI E-231-1999-0-PCT-02 Mutant of RAD51 Gene and Its Use in the Diagnosis of Predisposition to Breast Cancer PCT PCT PCT/US00/024786 Abandoned
NIDCR E-160-2000-0-EP-07 T2E, A Novel Family of Taste Receptors EP National Stage 00961750.7 Abandoned
NIEHS E-170-2000-0-US-01 A Non-Steroidal Anti-Inflammatory Drug Activated Gene With Anti-Tumorigenic Properties US 60/231,246 Abandoned
NIDCR E-160-2000-0-CA-04 T2R, A NOVEL FAMILY OF TASTE RECEPTORS CA National Stage 2384777 Abandoned
NIDCR E-160-2000-0-CN-13 T2R, a Novel Family of Taste Receptors CN DIV 200610159852.0 Abandoned
NCI E-256-1999-0-CA-04 Determination of AM-Binding Proteins and the Association of Adrenomedullin (AM) Therewith CA National Stage 2383419 Abandoned
NIDCR E-160-2000-0-NO-10 SF, a Novel Family of Taste Receptors NO National Stage 20021164 Abandoned
NCI E-163-1993-0-US-03 Recombinant Disulfide-Stabilized Polypeptide Fragments Having Binding Specificity US DIV 09/657,274 6558672 Expired PDF
NCI E-307-2000-0-US-01 Use of 14-3-3 Sigma as a Diagnostic Marker and Therapeutic Target US 60/231,192 Abandoned
NHLBI E-192-2000-0-US-01 Methods and Reagents For Modulating Response to Genotoxic Stress US 60/230,476 Abandoned
NIEHS E-080-1994-0-AU-05 DIAGNOSTIC METHODS AND GENE THERAPY USING REAGENTS DERIVED FROM THE HUMAN METASTASIS SUPPRESSOR GENE KAI1 AU DIV 56452/00 Abandoned
NIAID E-203-1999-0-EP-03 Identification of the Domain of Plasmodium Falciparum Erythrocyte Membrane Protein 1(PFEMP1) that Mediates Adhesion to Chondroitin Sulfate A EP National Stage 00961513.9 Abandoned
NICHD E-020-1999-0-US-02 Method of Immunizing Humans Against Salmonella Typhi Using a VI-REPA Conjugate Vaccine US CIP 09/653,433 6797275 Expired PDF
NICHD E-274-2000-0-PCT-01 Vibrio Cholerae O139 Conjugate Vaccines PCT PCT PCT/US00/24119 Expired
NIAID E-203-1999-0-PCT-02 Identification of the Domain of Plasmodium Falciparum Erythrocyte Membrane Protein 1(PFEMP1) that Mediates Adhesion to Chondroitin... PCT PCT PCT/US00/24195 Abandoned
NCI E-302-2000-0-US-01 Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway As Selective Therapeutic Strategy Against Melanomas US 60/229,290 Abandoned
NCI E-161-2000-0-US-01 XAGE-1, A GENE EXPRESSED IN MULTIPLE CANCERS, AND USES THEREOF US 60/229,684 Abandoned
NIAID E-152-1995-1-US-02 Hepatitis A Virus Vaccines US DIV 09/653,499 6423318 Abandoned PDF
NCI E-119-2001-0-JP-01 Human Malignant Melanoma Antigen JP ORD 2000-263725 Abandoned
NCI E-183-1996-0-US-04 Identification of TRP-2 as a Human Tumor Antigen Recognized By Cytotoxic T Lymphocytes US DIV 09/651,210 7001600 Abandoned PDF
CC E-202-2000-0-US-01 Method For Measurement of Stenosis From Magnetic Resonance Angiography Using Vessel Skeletons US 60/229,017 Abandoned
NCI E-033-1999-0-US-06 High Speed Parallel Molecular Nucleic Acid Sequencing US CON 12/886,686 8535881 Abandoned PDF
NCI E-033-1999-0-PCT-02 High Speed Parallel Molecular Nucleic Acid Sequencing PCT PCT PCT/US2000/023736 Expired
NCI E-076-1997-1-EP-04 Substituted Benzimidazoles as Non-Nucleoside Inhibitors of Reverse Transcriptase EP National Stage 00959441.7 Abandoned
NCI E-013-1998-0-US-07 DISUBSTITUTED LAVENDUSTIN A ANALOGS AND PHARMACEUTICAL COMPOSITION COMPRISING THE ANALOGS US National Stage 09/623,000 6943191 Abandoned PDF
NCI E-061-1999-0-PCT-02 Polypeptides Comprising IL-6 Ligand-Binding Receptor Domains and Relat ed Nucleic Acids, Antibodies, Compositions and Methods of Use PCT PCT PCT/US00/23490 Expired
NCI E-245-1999-0-PCT-02 Polypeptides that Bind HIV gp120 and Related Nucleic Acids, Antibodies, Compositions, and Methods of Use PCT PCT PCT/US2000/023505 Expired
NCI E-076-1997-1-PCT-03 Substituted Benzimidazoles As Non-Nucleoside Inhibitors of Reverse Transcriptase PCT PCT PCT/US2000/023449 Expired
NCI E-335-1994-4-US-01 GTPase ERA US CIP 09/648,103 Abandoned
NICHD E-259-2000-0-US-01 Protein Kinase A and Carney Complex US 60/228,211 Abandoned
NCI E-042-1998-0-US-03 DLC-1 Gene Deleted in Cancers US ORD 09/644,947 6897018 Abandoned PDF
NCI E-003-1998-0-US-07 Therapeutic Blockade of Icer Synthesis To Prevent Icer-Mediated Inhibition of Immune Cell Activity US ORD 09/643,548 Abandoned
NCI E-262-2000-0-US-01 SH2 Domain Binding Inhibitors US 60/226,671 Abandoned
NIAID E-171-1988-1-US-03 Chimeric and/or Growth-Restricted Flaviviruses US ORD 09/643,217 6676936 Expired PDF
NIDDK E-279-2000-1-US-01 Novel Compositions For The Treatment of Heart Failure US CIP 09/641,491 Abandoned
NCI E-123-2000-0-US-01 Method of Treating Cutaneous T-Cell Lymphoma By Administering A Histone Deacetylase Inhibitor US 60/226,234 Abandoned
NICHD E-286-1998-1-EP-05 Orally Active Peptides that Prevent Cell Damage and Death EP National Stage 00957607.5 Abandoned
NICHD E-286-1998-1-LU-16 Orally Active Peptides that Prevent Cell Damage and Death LU EP 00957607.5 Abandoned
NICHD E-286-1998-1-NL-13 Orally Active Peptides That Prevent Cell Damage and Death NL EP 00957607.5 Abandoned
NICHD E-286-1998-1-ES-12 Orally Active Peptides that Prevent Cell Damage and Death ES EP 00957607.5 Abandoned